Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)

CAPS Rating: 1 out of 5

A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers.

Recs

0
Player Avatar pchop123 (80.21) Submitted: 10/24/2013 3:56:38 PM : Underperform Start Price: $2.75 ONCY Score: +5.69

downward outlook

Featured Broker Partners


Advertisement